0000899140-24-000673.txt : 20240625 0000899140-24-000673.hdr.sgml : 20240625 20240625161611 ACCESSION NUMBER: 0000899140-24-000673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240623 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DONG-A ST CO., LTD CENTRAL INDEX KEY: 0001799260 ORGANIZATION NAME: STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 241069156 BUSINESS ADDRESS: STREET 1: 64, CHEONHO-DAERO STREET 2: DONGDAEMUN-GU CITY: SEOUL STATE: M5 ZIP: 02587 BUSINESS PHONE: 82-2-920-8184 MAIL ADDRESS: STREET 1: 64, CHEONHO-DAERO STREET 2: DONGDAEMUN-GU CITY: SEOUL STATE: M5 ZIP: 02587 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 form4.xml X0508 4 2024-06-23 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001799260 DONG-A ST CO., LTD 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 KOREA, REPUBLIC OF true false Common Stock 2024-06-23 4 P 0 2544530 3.13 A 5348229 D Dong-A St Co., Ltd.; By: /s/ Min Young Kim, Chief Executive Officer 2024-06-25